Oh, Hyuck-Jin
(Department of Neurosurgery, Soonchunhyang University Cheonan Hospital)
,
Lee, Kyeong-Seok
(Department of Neurosurgery, Soonchunhyang University Cheonan Hospital)
,
Shim, Jae-Jun
(Department of Neurosurgery, Soonchunhyang University Cheonan Hospital)
,
Yoon, Seok-Mann
(Department of Neurosurgery, Soonchunhyang University Cheonan Hospital)
,
Yun, Il-Gyu
(Department of Neurosurgery, Soonchunhyang University Cheonan Hospital)
,
Bae, Hack-Gun
(Department of Neurosurgery, Soonchunhyang University Cheonan Hospital)
Objective : Chronic subdural hematoma (CSDH) is known to have a significant recurrence rate. There are different criteria defining the recurrence of CSDH. We evaluated the postoperative course of CSDH and tried to propose the reasonable criteria of recurrence. Methods : We retrospectively examined t...
Objective : Chronic subdural hematoma (CSDH) is known to have a significant recurrence rate. There are different criteria defining the recurrence of CSDH. We evaluated the postoperative course of CSDH and tried to propose the reasonable criteria of recurrence. Methods : We retrospectively examined the medical records and pre- and postoperative CT scans of 149 consecutive patients who underwent surgery from January 2005 to December 2009. Diagnosis was confirmed by CT scanning or MRI. The postoperative courses were either resolved or recurrent. The resolved CSDH was one of the three types; early resolution, delayed resolution, or late resolution. The recurrent CSDH was one of the four types; recurrence without resolution, early recurrence after resolution, late recurrence after resolution, or recurrent-and-resolved type. Results : The CSDH was resolved within 30 days after surgery in 58 (39%) patients, between 1 to 3 months in 62 (42%), and after 3 months in 11 (7%) patients. The CSDH was recurred in 18 (12%) patients. Late resolution or recurrence was more common in the aged. The recurrent hematoma was seen on the same side in 11 patients, on the different side in 7 patients. Recurrence was significantly more common in the thick hematomas. Conclusion : For a working criteria of the recurrence of CSDH, we propose the early recurrence as return of symptoms or reaccumulation of the hematoma after a surgery within 3 months regardless of the location, amount or repeated operations. The late recurrence can be defined as reappearance or enlargement of a liquefied hematoma within the cranial cavity surrounded by the membranes or persistent CSDH beyond 3 months after surgery.
Objective : Chronic subdural hematoma (CSDH) is known to have a significant recurrence rate. There are different criteria defining the recurrence of CSDH. We evaluated the postoperative course of CSDH and tried to propose the reasonable criteria of recurrence. Methods : We retrospectively examined the medical records and pre- and postoperative CT scans of 149 consecutive patients who underwent surgery from January 2005 to December 2009. Diagnosis was confirmed by CT scanning or MRI. The postoperative courses were either resolved or recurrent. The resolved CSDH was one of the three types; early resolution, delayed resolution, or late resolution. The recurrent CSDH was one of the four types; recurrence without resolution, early recurrence after resolution, late recurrence after resolution, or recurrent-and-resolved type. Results : The CSDH was resolved within 30 days after surgery in 58 (39%) patients, between 1 to 3 months in 62 (42%), and after 3 months in 11 (7%) patients. The CSDH was recurred in 18 (12%) patients. Late resolution or recurrence was more common in the aged. The recurrent hematoma was seen on the same side in 11 patients, on the different side in 7 patients. Recurrence was significantly more common in the thick hematomas. Conclusion : For a working criteria of the recurrence of CSDH, we propose the early recurrence as return of symptoms or reaccumulation of the hematoma after a surgery within 3 months regardless of the location, amount or repeated operations. The late recurrence can be defined as reappearance or enlargement of a liquefied hematoma within the cranial cavity surrounded by the membranes or persistent CSDH beyond 3 months after surgery.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
대상 데이터
The CSDH was recurred in 18 patients (Table 4). The recurrent hematoma was on the same side in 11 patients, on the different side in 7 patients.
The recurrent hematoma was on the smae side in 11 patients, on the different side in 7 patients. Recurrence , based on medical dictionary, is defined as the returen of symptoms after a remission.
데이터처리
Statistical significance was tested using the chi-square test. It was considered significant, when p < 0.
참고문헌 (23)
Abouzari M, Rashidi A, Rezaii J, Esfandiari K, Asadollahi M, Aleali H, et al. : The role of postoperative patient posture in the recurrence of traumatic chronic subdural hematoma after burr-hole surgery. Neurosurgery 61 : 794-797, 2007
Amirjamshidi A, Abouzari M, Eftekhar B, Rashidi A, Rezaii J, Esfandiari K, et al. : Outcomes and recurrence rates in chronic subdural hematoma. Br J Neurosurg 21 : 272-275, 2007
Fogelholm R, Heiskanen O, Waltimo O : Chronic subdural hematoma in adults. Influence of patient's age on symptoms, signs, and thickness of hematoma. J Neurosurg 42 : 43-46, 1975
Gelabert-Gonzalez M, Iglesias-Pais M, Garcia-Allut A, Martinez- Rumbo R : Chronic subdural hematoma : surgical treatment and outcome in 1000 cases. Clin Neurol Neurosurg 107 : 223-229, 2005
Ko BS, Lee JK, Seo BR, Moon SJ, Kim JH, Kim SH : Clinical analysis of risk factors related to recurrent chronic subdural hematoma. J Korean Neurosurg Soc 43 : 11-15, 2008
Lee KS, Bae WK, Yoon SM, Doh JW, Bae HG, Yun IG : Location of the chronic subdural hematoma : role of the gravity and cranial morphology. Brain Inj 15 : 47-52, 2001
Matsumoto K, Akagi K, Abekura M, Ryujin H, Ohkawa M, Iwasa N, et al. : Recurrence factors for chronic subdural hematomas after burrhole craniostomy and closed system drainage. Neurol Res 21 : 277- 280, 1999
Murakami H, Hirose Y, Sagoh M, Shimizu K, Kojima M, Gotoh K, et al. : Why do chronic subdural hematomas continue to grow slowly and not coagulate? Role of thrombomodulin in the mechanism. J Neurosurg 96 : 877-884, 2002
Nakaguchi H, Tanishima T, Yoshimasu N : Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 95 : 256-262, 2001
Okada Y, Akai T, Okamoto K, Iida T, Takata H, Iizuka H : A comparative study of the treatment of chronic subdural hematoma-burr hole drainage versus burr hole irrigation. Surg Neurol 57 : 405-409, 2002
Santarius T, Kirkpatrick PJ, Ganesan D, Chia HL, Jalloh I, Smielewski P, et al. : Use of drains versus no drains after burr-hole evacuation of chronic subdural hematoma : a randomised controlled trial. Lancet 374 : 1067-1073, 2009
Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S : Independent predictors for recurrence of chronic subdural hematoma : a review of 343 consecutive surgical cases. Neurosurgery 63 : 1125-1129, 2008
Tsai TH, Lieu AS, Hwang SL, Huang TY, Hwang YF : A comparative study of the patients with bilateral or unilateral chronic subdural hematoma : precipitating factors and postoperative outcomes. J Trauma 68 : 571-575, 2010
Weigel R, Hohenstein A, Schlickum L, Weiss C, Schilling L : Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism. Neurosurgery 61 : 788-792, 2007
Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S : Independent predictors of recurrence of chronic subdural hematoma : results of multivariate analysis performed using a logistic regression model. J Neurosurg 98 : 1217-1221, 2003
※ AI-Helper는 부적절한 답변을 할 수 있습니다.